Show simple item record

dc.contributor.authorCuzick, Jack
dc.contributor.authorSestak, Ivana
dc.contributor.authorForbes, John F.
dc.contributor.authorDowsett, Mitch
dc.contributor.authorKnox, Jill
dc.contributor.authorCawthorn, Simon
dc.contributor.authorSaunders, Christobel
dc.contributor.authorRoche, Nicola
dc.contributor.authorMansel, Robert E.
dc.contributor.authorvon Minckwitz, Gunter
dc.contributor.authorBonanni, Bernardo
dc.contributor.authorPalva, Tiina
dc.contributor.authorHowell, Anthony
dc.contributor.authorIBIS-II investigators
dc.date.accessioned2018-12-04T09:20:08Z
dc.date.available2018-12-04T09:20:08Z
dc.date.issued2014-03-22
dc.identifier.citationCuzick , J , Sestak , I , Forbes , J F , Dowsett , M , Knox , J , Cawthorn , S , Saunders , C , Roche , N , Mansel , R E , von Minckwitz , G , Bonanni , B , Palva , T , Howell , A & IBIS-II investigators 2014 , ' Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trial ' , The Lancet , vol. 383 , no. 9922 , pp. 1041-1048 . https://doi.org/10.1016/S0140-6736(13)62292-8en
dc.identifier.issn0140-6736
dc.identifier.otherPURE: 104738362
dc.identifier.otherPURE UUID: a9a8da32-6b94-4a38-9a78-2d0e94c0cd48
dc.identifier.otherPubMed: 24333009
dc.identifier.otherScopus: 84896489393
dc.identifier.urihttp://hdl.handle.net/2164/11551
dc.descriptionThis study was funded by Cancer Research UK (C569/A5032), the National Health and Medical Research Council Australia (GNT300755, GNT569213), Sanofi-Aventis, and AstraZeneca. Sanofi-Aventis and AstraZeneca provided anastrozole and matching placebo. The study sponsor was Queen Mary University of London.en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofThe Lanceten
dc.rights© Cuzick et al. Open Access article distributed under the terms of CC BY https://creativecommons.org/licenses/by/3.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectCancer Research UKen
dc.subjectC569/A5032en
dc.subject.lccRen
dc.titleAnastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/S0140-6736(13)62292-8
dc.identifier.vol383en
dc.identifier.iss9922en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record